COMP <GO>
IOVA vs RLAY // PIOTROSKI F-SCORE QUALITY
Iovance Biotherapeutics Inc. (NASDAQ) VS. Relay Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: IOVA 2
— RLAY 2
■ METRIC PARITY
LAST: $9.56 (-35.45%) • MKT CAP: $4.33B
piotroski-score
4/9
LAST: $19.47 (-1.12%) • MKT CAP: $4.27B
piotroski-score
4/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IOVA VS. RLAY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IOVA | RLAY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 34.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.76% | -5.53% | -2.23 | RLAY | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 60.60% | 53.40% | +7.20 | IOVA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.08 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.8 | 50.0 | -13.19 | RLAY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.0x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.33B | $4.27B | $63.7M | IOVA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IOVA REV | RLAY REV | IOVA GROSS % | RLAY GROSS % | IOVA FCF | RLAY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $263.5M | $15.4M | 34.3% | — | -$336.2M | -$235.9M |
| FY 2024 | $164.1M | $10.0M | 43.2% | — | -$364.0M | -$251.1M |
| FY 2023 | $1.2M | $25.5M | — | — | -$361.9M | -$300.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IOVA // BETA 0.99
RLAY // BETA —